Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:pomalidomide
|
| gptkbp:approvalYear |
2013
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:European_Medicines_Agency |
| gptkbp:ATCCode |
L04AX06
|
| gptkbp:CASNumber |
19171-19-8
|
| gptkbp:chemicalFormula |
C13H11N3O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
Imnovid
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketingAuthorizationHolder |
gptkb:Bristol_Myers_Squibb
|
| gptkbp:mechanismOfAction |
immunomodulatory agent
|
| gptkbp:pregnancyCategory |
contraindicated
|
| gptkbp:relatedTo |
gptkb:thalidomide
gptkb:lenalidomide |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
fatigue infections neutropenia thrombocytopenia |
| gptkbp:usedFor |
multiple myeloma
|
| gptkbp:bfsParent |
gptkb:pomolidomide
|
| gptkbp:bfsLayer |
7
|